Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-07

Clinical Trial Update: Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial comparing clemastine fumarate with dexamethasone to dexchlorpheniramine in eczema; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clemastine fumarate + dexamethasone (clemastine fumarate, dexamethasone)
  • Dexchlorpheniramine maleate (dexchlorpheniramine maleate)

Snippet

Sponsor: EMS | Conditions: Eczema | Phase 3 | Status: COMPLETED